Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). - Wikidata - awgldk - TriplyDB

Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study).

Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study).

http://www.wikidata.org/entity/Q37595974

about

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Rate Control Strategy Elevated To Primary Treatment For Atrial Fibrillation: Has The Last Word Already Been Spoken?Termination of persistent atrial fibrillation during pulmonary vein isolation: insight from the MAGIC-AF trial.The modified stepwise ablation guided by low-dose ibutilide in chronic atrial fibrillation trial (The MAGIC-AF Study).Quality-of-life benefits of catheter ablation of persistent atrial fibrillation: a reanalysis of data from the SARA study.Left atrial strain predicts recurrence of atrial arrhythmias after catheter ablation of persistent atrial fibrillation.Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial.Long-term stroke rates after catheter ablation or antiarrhythmic drug therapy for atrial fibrillation: a meta-analysis of randomized trials.The serum matrix metalloproteinase-9 level is an independent predictor of recurrence after ablation of persistent atrial fibrillation Long-term outcomes after ablation of persistent atrial fibrillation: an observational study over 6 years.Catheter ablation in patients with persistent atrial fibrillation The year in cardiology 2014: arrhythmias and device therapy.Clinical Relevance of Left Atrial Strain to Predict Recurrence of Atrial Fibrillation after Catheter Ablation: A Meta-Analysis.Assessing quality-of-life outcomes in cardiovascular clinical research.Impact of Additional Transthoracic Electrical Cardioversion on Cardiac Function and Atrial Fibrillation Recurrence in Patients with Persistent Atrial Fibrillation Who Underwent Radiofrequency Catheter Ablation Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry.Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.Management of Atrial Fibrillation in Elderly Adults.New Insights On Ablation Of Persistent Atrial Fibrillation: Evidence From The SARA Trial.Clinical, electrophysiological and imaging predictors of atrial fibrillation ablation outcome.The effects of gender on electrical therapies for the heart: physiology, epidemiology, and access to therapies: A report from the XII Congress of the Italian Association on Arrhythmology and Cardiostimulation (AIAC).Persistent atrial fibrillation vs paroxysmal atrial fibrillation: differences in management.Novel association of polymorphic genetic variants with predictors of outcome of catheter ablation in atrial fibrillation: new directions from a prospective study (DECAF).Connexin 43 is involved in the sympathetic atrial fibrillation in canine and canine atrial myocytes.A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.Recent advances in rhythm control for atrial fibrillation.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary.Moving catheter ablation forward from paroxysmal to persistent atrial fibrillation: progress, limitations, and surprises of the SARA trial Altered atrial metabolism: an underappreciated contributor to the initiation and progression of atrial fibrillation.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.Adjunctive Therapies for Catheter Ablation of Non-Paroxysmal Atrial Fibrillation.Effectiveness of catheter ablation of atrial fibrillation: are we at the dawn of a new era?Five-year clinical outcomes of visually guided laser balloon pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation.Second generation cryoballoon ablation for persistent atrial fibrillation: an updated meta-analysis.Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent atrial fibrillation: a randomized clinical trial.Impact of treatment crossovers on clinical outcomes in the rate and rhythm control strategies for atrial fibrillation: Insights from the AFFIRM (Atrial Fibrillation Follow-up Investigation of Rhythm Management) trial.Staged hybrid procedure in persistent atrial fibrillation: safety, efficacy, and atrial tachyarrhythmia.

P2860

Q27341873-736C63F2-B27E-44CB-B9A6-4A5058A46807 Q28081709-BB25F072-4997-4689-9BDD-C9DAE72F9399 Q30275791-9F11BA3C-B052-47B9-ACAF-AD3563076A97 Q30277395-D5DC2B75-90A9-4A9B-BF71-2A0C4CCA0211 Q30836657-3CC5E7AA-9C75-4EAF-9D2A-02A6289C4E72 Q33801860-98C2B3ED-863D-4AEF-BB42-0F584BB0C8E8 Q35036404-131258CB-3128-414D-9F4E-3C96B9CE1108 Q36162187-3F161709-6734-476D-9C55-94058866A258 Q36920563-EC778613-A8E1-4B16-B3E6-3710D45E6B76 Q37156455-F1F5AF00-EC6A-4D2C-A3DB-5EBC066D4238 Q37704983-E58EA62C-E3E9-4820-9466-409F04489D7B Q38307425-7446FDE9-882A-414A-A36D-5592C06BAD56 Q38726657-6A777E93-92CC-4104-A32A-34B7CB938603 Q38737960-18FD695B-0235-4242-A08E-1BCAFD4C125D Q38955756-F9A4157F-0A1F-4986-B7E0-561CC9360156 Q39011211-05D8AB78-2A44-4F82-87E3-90DCEC6A741E Q39015608-5AFF9211-BC25-45EB-9196-E6802E579A64 Q39026788-982010CB-5C74-425A-8478-4ED8A92170B5 Q39037023-2B9914AA-B56C-48DC-A557-0747486D86CE Q39166055-AF9324FF-D60B-47A9-831C-AC501F0D6567 Q39318361-3AF34620-39D9-438C-B506-CBAFF06E6A48 Q39445718-BB108E92-4E51-41F2-82E3-F88601F431A3 Q40397117-36689528-D8B0-4E48-AB5C-432669136D99 Q41026703-C1675F2E-B1AC-45DA-B5D6-E00FE53ED049 Q41150472-12FD24EE-5240-424F-9850-A58763CD73ED Q42172443-37C2DBDC-4AF4-413E-AFB6-90F1F7F758BC Q42370098-AA6C3C16-C565-4DCF-825E-0926D2C87C83 Q42373398-2156930D-F35C-48FA-8313-082324606256 Q42435302-F9DF5B42-073E-4E40-BF06-B6488F33231A Q43226639-308257AD-A8C8-4319-9916-FA45ADE7300D Q45059153-6757427B-E5E2-4A75-8B58-2712FDD558C9 Q45069696-1FE5644D-6BB4-4F5C-8174-3F4CFE597718 Q46658026-23E9EFF3-B637-4CD1-9BD0-C3DA92301D88 Q47102409-A060BC18-AF2B-43AD-89B3-E4AA5D24DB15 Q47134346-D5718FF1-A13F-4BB9-94E4-CD9F546C010A Q47559367-A30A63E2-0D0F-49BA-AE3E-36B7491B60BF Q47707036-351AEFAD-6766-401E-BE45-6B3F548B8699 Q48086632-B98C893A-3C8A-453E-8173-707271AC6B50 Q48098890-E28C0C4E-2FD3-4AB5-88C5-6034F6BFFECE Q49235722-D3C9BC75-8C8A-498D-8A09-54C52BF92FFE

P2860

Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study).

http://www.wikidata.org/entity/Q37595974

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Catheter ablation vs. antiarrh ...... controlled trial (SARA study).

@en

Catheter ablation vs. antiarrh ...... controlled trial (SARA study).

@nl

type

label

Catheter ablation vs. antiarrh ...... controlled trial (SARA study).

@en

Catheter ablation vs. antiarrh ...... controlled trial (SARA study).

@nl

prefLabel

Catheter ablation vs. antiarrh ...... controlled trial (SARA study).

@en

Catheter ablation vs. antiarrh ...... controlled trial (SARA study).

@nl

P1433

Q37595974-9F65C2AD-4BC6-48C1-B0D4-C6A49EB239C3

P1476

Q37595974-546935FF-EE96-437C-A5D3-1F172AE500B1

P2093

Q37595974-115433AF-D6B9-4515-83CE-EA28DF70ED81

Q37595974-3CCA74DB-FF73-4DF8-8E40-D6B653EC9DBD

Q37595974-51013DB2-19A7-47D2-9CC3-2D6545713A12

Q37595974-560B8FCB-6592-49E8-918E-58F1E8BE08A9

Q37595974-58534DF9-DAD5-4064-B9CC-8E6AA0619D51

Q37595974-6630ABE7-1069-4CC2-A12F-92BD4BF3F9C9

Q37595974-66A26810-7514-4E79-AB58-68ACE911C905

Q37595974-B32E649E-2E18-4E54-889F-9DDC57BF2925

Q37595974-B56CA687-26C9-45A6-9586-DE2892555F54

Q37595974-BC2A33E0-1F7E-462A-8CA2-32CBABAAE4DD

P2860

Q37595974-12B409E8-95FF-4FBB-8824-DE6ED39F1253

Q37595974-1434B411-5149-4A51-A67B-57C30A68BBD5

Q37595974-2D03E489-BDCC-48D8-943C-7EECA5EB40C0

Q37595974-33B7EADA-0540-4FCA-B096-EAC845E87A85

Q37595974-4D83140C-7EE0-4377-AAB9-6AEFFD975490

Q37595974-5FBBF38A-06A6-48C5-BBF6-C5F36A141725

Q37595974-61655A58-436F-40B4-9BB6-F5FF18F0AA47

Q37595974-6DFF843D-1E02-4500-9B88-9C1A7046343A

Q37595974-84618483-41D3-4742-9D4A-2C6DC7103807

Q37595974-846AE8BB-E311-49DB-AB4A-5E12168D949C

P304

Q37595974-3626BBFC-CB37-4FBF-970A-B881A2C63352

P31

Q37595974-DBCB96FF-E2BD-4962-873F-EED36A4A1814

P356

Q37595974-822409E9-F61A-4743-8BFD-72B775F40646

P433

Q37595974-F6714011-CAF2-473A-B221-8CEB5035BEF4

P478

Q37595974-96FD1D79-CC03-49C2-B40D-3509D091C435

P50

Q37595974-0A782019-2651-4B6F-B0AB-94178EC08170

Q37595974-139289DC-95F5-4ED9-9CF2-88304460EAB7

Q37595974-13EB59F5-697D-4B7A-96ED-58C653D9684A

Q37595974-6D4F7C23-48D3-421F-B53A-481946487B91

Q37595974-BFC9ED60-2FD0-41FA-91F1-76A2FDD4993C

P577

Q37595974-2F0F8ABA-390A-4D67-81FD-2A715D0BAFF8

P5875

Q37595974-E4AF4E25-4EEA-4B39-A665-09013FC01282

P698

Q37595974-CF7B01AB-3D51-4EAE-B539-22032ADCA335

P921

Q37595974-137C1397-C439-45E8-B009-E5C58F8BCAB1

Q37595974-393E0F2C-E823-4DDC-898B-AF805CA7B139

Q37595974-B27085BE-3C19-4EA3-882C-0CC6898AD407

Q37595974-EA622845-387C-455D-97AE-C3032EBC6C40

P932

Q37595974-51D8A5BE-3972-497B-BF08-75D6C73DA851

P356

P1433

European Heart Journal

P1476

Catheter ablation vs. antiarrh ...... controlled trial (SARA study)

@en

P2093

Albert Cobos

http://www.w3.org/2001/XMLSchema#string

Andrés Bodegas

http://www.w3.org/2001/XMLSchema#string

Angel Arenal

http://www.w3.org/2001/XMLSchema#string

Antonio Hernández-Madrid

http://www.w3.org/2001/XMLSchema#string

Ignacio Fernández-Lozano

http://www.w3.org/2001/XMLSchema#string

Josep Brugada

http://www.w3.org/2001/XMLSchema#string

José Ignacio Arana

http://www.w3.org/2001/XMLSchema#string

Julián Pérez-Villacastín

http://www.w3.org/2001/XMLSchema#string

Lluís Mont

http://www.w3.org/2001/XMLSchema#string

Nicasio Pérez-Castellano

http://www.w3.org/2001/XMLSchema#string

P2860

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias.

Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis.

Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses.

Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review.

Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review.

Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study.

Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study.

Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs.

P304

501-507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHT457

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Fernando Arribas

P577

2013-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262044848

http://www.w3.org/2001/XMLSchema#string

P698

24135832

http://www.w3.org/2001/XMLSchema#string

P921

catheterization

catheter ablation

multicenter trial

atrial fibrillation

P932

3930872

http://www.w3.org/2001/XMLSchema#string